HIV Integrated Epidemiological Profile, Florida, 2024, as of 06/30/2025
Data for 2020 and 2021 should be interpreted with caution due to the impact of a public health emergency on HIV testing, care-related services, and case surveillance activities in state and local jurisdictions.
Analyzes, and disseminates surveillance data to create the HIV Epidemiological Profile. The Epidemiological Profile is a document that describes the burden of HIV on the Florida population in terms of sociodemographic, geographic, behavioral, and clinical characteristics of persons living with an HIV diagnosis in Florida. This profile is a valuable tool used at the state and local levels among HIV programmatic staff, community partners, and the public for allocating HIV prevention and care resources, planning programs, and evaluating programs and policies.
Technical Notes
HIV and AIDS are diagnosed in Florida based on the case definition as described in the Technical Notes section of the CDC HIV Surveillance Report at the following link: https://www.cdc.gov/nchhstp/director-letters/cdc-publishes-new-hiv-surveillance-reports.html
HIV diagnoses by year of diagnosis represent persons whose HIV was diagnosed in that year, regardless of AIDS status at time of diagnosis.
HIV and AIDS diagnoses by year of diagnosis are not mutually exclusive and cannot be added together.
HIV prevalence data represent persons living with an HIV diagnosis (PWH) in the area through the end of the calendar year regardless of residence at diagnosis.
Adult diagnoses represent persons age 13 and older; pediatric diagnoses represent persons under the age of 13. For diagnosis data, the age is categorized by the age at diagnosis. For prevalence data, the age is categorized by the current age at the end of the calendar year, regardless of the age at diagnosis.
For race/ethnicity, unless otherwise noted, Whites are non-Hispanic, Blacks are non-Hispanic and Other represents Asian, American Indian/Alaska Native, Native Hawaiian/Pacific Islander, or Multi-race.
For HIV or AIDS diagnoses by year, area and county data will exclude diagnoses where the residence at diagnosis was listed as Florida Department of Corrections or Federal Correctional Institution (FDC/FCI). For prevalence data, FDC/FCI diagnoses will not be excluded from area and county data.
Percents of total for individual populations may not sum up to 100% due to rounding.
HIV-related death data represent PWH with HIV listed as the underlying cause of death and a residence at death in this area in the period specified. These data will vary from the HIV-related deaths generated by the Office of Vital Statistics posted on FLHealthCHARTS.
All transmission categories are mutually exclusive. In Florida, a small proportion of HIV diagnoses are reported without an identified risk factor and multiple imputation is used to assign a transmission category. Multiple imputation is a statistical approach in which each missing transmission category is replaced with a set of plausible values based on the average risks for the population to compensate for the uncertainty about the true risk for these persons.
MMSC: male-to-male sexual contact; the term MMSC indicates a behavior that is associated with HIV transmission IDU: injection drug use.
MMSC/IDU: male-to-male sexual contact and injection drug use.
Heterosexual Contact: heterosexual contact with a person living with HIV or with a known HIV risk.
Other Risk: includes hemophilia, transfusion, perinatal and other pediatric risks, and other confirmed risks.
Eligible Metropolitan Areas (EMA) and Partnerships Breakdown
Continuum of HIV Care Definitions
Persons with HIV: The number of persons living in Florida with an HIV diagnosis (PWH) at the end of the year specified
In Care: PWH with at least one documented VL or CD4 lab, medical visit, or prescription from January 1 of the year specified through March 31 of the following year
In Care 7 Days: Linked to care within 7 days of HIV diagnosis date
In Care 30 Days: Linked to care within 30 days of HIV diagnosis date
Out of Care: PWH with no documented VL or CD4 lab, medical visit, or prescription from January 1 of the year specified through March 31 of the following year
Retained in Care: PWH with two or more documented VL or CD4 labs, medical visits, or prescriptions at least three months apart from January 1 of the year specified through June 30 of the following year
Suppressed Viral Load: PWH with a suppressed VL (<200 copies/mL) on the last VL from January 1 of the year specified through March 31 of the following year
In Care with Suppressed Viral Load: PWH with at least one documented VL or CD4 lab, medical visit, or prescription from January 1 of the year specified through March 31 of the following year that also has a suppressed VL (<200 copies/mL) on the last VL from January 1 of the year specified through March 31 of the following year
Retained in Care with Suppressed Viral Load: PWH with two or more documented VL or CD4 labs, medical visits, or prescriptions at least three months apart from January 1 of the year specified through June 30 of the following year that also has a suppressed VL (<200 copies/mL) on the last VL from January 1 of the year specified through March 31 of the following year
No VL: No documented VL from January 1 of the year specified through March 31 of the following year
Late Diagnosis: AIDS diagnosis within 3 months of HIV diagnosis
Florida Population Estimates
Population estimates are provided by the Office of Vital Statistics. These estimates are based on the Florida Legislature's Office of Economic and Demographic Research’s (EDR) midyear population estimates (July 1) and are final as of the release of Vital Statistics annual data.